Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Financing Arrangements

30 Sep 2009 15:07

RNS Number : 9643Z
Mavinwood PLC
30 September 2009
 



Financing Arrangements

Mavinwood plc ("Mavinwood" or the "Company") announces that it has reached agreement with Lloyds to amend the facility agreement dated 29 July 2009 that Mavinwood entered into with Lloyds TSB Bank plc (the "Lloyds Facility"). In connection with the amendment of the Lloyds Facility, Mavinwood has entered into subordinated working capital facilities with Geraldton Services, Inc. ("Geraldton") as follows (the "Subordinated Loans"):

a new £3.1 million facility due to be repaid on 1 August 2012 with interest to be compounded annually and paid on the date of repayment of the loan. It is intended that the £3.1 million loan will be used to reduce outstanding bank borrowings; and

in substitution for the £2.5 million short term facility previously made available by Geraldton, a new £2 million facility due to be repaid on 1 August 2012 with interest to be compounded annually and paid on the date of repayment of the loan.

Under the terms of the Lloyds Facility, Mavinwood was required to raise a minimum of £6 million (gross) in cash by 30 September 2009. The Lloyds Facility has been amended and now requires a minimum equity injection by 31 December 2009 of an amount equal to (i) the Subordinated Loans (including rolled-up interest) plus (ii) the previously announced fee of £900,000 payable to Geraldton in connection with their equity underwriting commitment The Geraldton underwriting fee and the Subordinated Loans (including interest) will become payable as and when the above equity investment is made.

Geraldton's underwriting commitment to invest a further sum of up to £4 million on or before 31 January 2010, should it be required, remains in place. Geraldton's underwriting commitment has been varied to reflect the above.

Geraldton is a related party (as defined in the AIM Rules) and the provision of the Subordinated Loans and variation of Geraldton's underwriting commitment constitute related party transactions under the AIM Rules (together the "Transaction"). The Board considers, having consulted with its nominated adviser, Collins Stewart, the terms of the Transaction to be fair and reasonable in so far as the Company's shareholders are concerned. For the purpose of considering the Transaction, Mr Wilson is not regarded as an "independent" director because of his formal links to Lord Ashcroft KCMG, who controls Geraldton. It was therefore agreed that Mr Wilson would not vote, and did not vote, at the Board meeting when the above related party transactions were voted on.

Enquiries to:

Mavinwood plc

Charles Skinner 07966 234075

Collins Stewart

Adrian Hadden 020 7523 8350

Threadneedle Communications

John Coles 020 7653 9848

Collins Stewart Europe Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as nominated adviser to Mavinwood plc and is acting for no-one else in connection with the related party transactions and will not be responsible to anyone other than Mavinwood plc for providing the protections afforded to clients of Collins Stewart Europe Limited nor for providing advice in connection with the related party transactions or any other matter referred to herein.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFBLFXKKBXBBZ
Date   Source Headline
4th Mar 20258:04 amRNSHolding(s) in Company
4th Feb 20259:23 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSNotice of full year results
21st Nov 20247:00 amRNSTrading Update
7th Nov 20247:00 amRNSNotice of Trading Update
31st Oct 20241:07 pmRNSHolding(s) in Company
24th Oct 20247:00 amRNSAnalyst and Investor Site Visit
22nd Oct 20242:26 pmRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSBoard Change
2nd Sep 20247:00 amRNSDirector/PDMR Shareholding
23rd Aug 20249:21 amRNSDirector/PDMR Shareholding
16th Aug 202410:27 amRNSHolding(s) in Company
31st Jul 20247:00 amRNSHalf year results 2024
7th Jun 20247:49 amRNSHolding(s) in Company
3rd Jun 20241:17 pmRNSHolding(s) in Company
20th May 20242:03 pmRNSGrant of SAYE Options and PDMR Dealings
16th May 20244:29 pmRNSResult of Annual General Meeting
16th May 20247:00 amRNSTrading Update
12th Apr 20243:48 pmRNSHolding(s) in Company
5th Apr 20243:39 pmRNSDirector/PDMR Shareholding
25th Mar 20248:59 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSFull year 2023 results
18th Jan 20247:00 amRNSTrading Update and Notice of Full Year Results
20th Dec 20237:00 amRNSHolding(s) in Company
18th Dec 202311:38 amRNSDirector/PDMR Shareholding
20th Nov 20234:07 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update, Contract Award and CME
30th Oct 20237:00 amRNSBoard Changes
24th Oct 20233:33 pmRNSHolding(s) in Company
11th Oct 202312:07 pmRNSDirector/PDMR Shareholding
6th Oct 20233:52 pmRNSDirector/PDMR Shareholding
25th Sep 202310:55 amRNSDirector/PDMR Shareholding
22nd Sep 20234:43 pmRNSNotification of Major Holdings
12th Sep 20237:00 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSBoard Changes
16th Aug 20237:00 amRNSInterim CFO Appointment
16th Aug 20237:00 amRNSHalf Year Results 2023
1st Aug 20233:23 pmRNSNotification of Major Holdings
19th Jul 20232:35 pmRNSNotification of Major Holdings
4th Jul 20237:01 amRNSBoard Changes
4th Jul 20237:00 amRNSTrading Update
22nd Jun 20236:08 pmRNSDirector/PDMR, Grant of LTIP
14th Jun 20237:00 amRNSBoard Change
24th May 20234:37 pmRNSNOTIFICATION OF MAJOR HOLDINGS
18th May 20233:42 pmRNSNotification of Major Holdings
16th May 20234:18 pmRNSResult of Annual General Meeting
15th May 20237:00 amRNSTrading Update
11th Apr 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.